USPTO trademark

REMIZY

Opposition periodUSPTOWord markClass 5

"REMIZY" is a word mark owned by Axsome Therapeutics, Inc., filed at the USPTO on July 24, 2026. It is in its opposition period and covers class 5 (Pharmaceuticals).

View Axsome Therapeutics, Inc. portfolioGet this data via the API
Official USPTO record
REMIZY trademark as filed
As filed with the USPTO
Status
Opposition period
Since September 29, 2026
Filed
July 24, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50012281
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns REMIZY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Axsome Therapeutics, Inc.

AXSM · New York, United States

150 trademarks in the portfolioView company

Representative

Brent A. Johnson

Procopio, Cory, Hargreaves & Savitch LLP

Goods and services

What the mark covers

The products and services REMIZY is filed for, grouped by Nice class.

  • Medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatment of cardiovascular, dermatological, respiratory, central nervous system, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, tissue and organ, ocular, ophthalmological, immune system, pain, kidney, urological, and bone diseases and disorders and for the treatment of fibromyalgia, smoking cessation, narcolepsy, cataplexy in narcolepsy, excessive daytime sleepiness, alzheimer's disease agitation, migraine, diabetes, hypertension, skin disorders, allergies, asthma, obesity, hair loss, epilepsy and tourette's schizophrenia

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Official gazette publication confirmation e-mailed
  2. Published for opposition
  3. Notification of notice of publication e-mailed
  4. Approved for pub - principal register
  5. Teas/email correspondence entered
  6. Correspondence received in law office
  7. Teas response to office action received
  8. Notification of non-final action e-mailed
  9. Non-final action e-mailed
  10. Non-final action written

4 earlier steps on the official record.

FAQ

About REMIZY

Who owns the trademark "REMIZY"?

The USPTO trademark "REMIZY" (application 50012281) is owned by Axsome Therapeutics, Inc.

What is the status of "REMIZY"?

Its status at the USPTO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull REMIZY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019f9960-01fa-760c-a801-eb2d4087d40b
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019f9960-01fa-760c-a801-eb2d4087d40b",
  "object": "trademark",
  "mark_text": "REMIZY",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "US",
  "application_number": "50012281",
  "filing_date": "2026-07-24",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Axsome Therapeutics, Inc.",
      "entity_id": "ent_019ebba6-3220-71b6-8fee-f721d26ca090"
    }
  ]
}